These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29503132)

  • 21. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
    Martin SD; McGinnis E; Smith TW
    Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombotic microangiopathy and indications for therapeutic plasma exchange.
    Adamski J
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):444-9. PubMed ID: 25696892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
    Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
    Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombotic microangiopathies.
    Rosove MH
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ; Taylor JA
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of thrombotic microangiopathies].
    Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
    Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and treatment of TMA based on Japanese clinical guides].
    Wada H; Hasegawa K; Watanabe M
    Rinsho Ketsueki; 2017; 58(7):849-856. PubMed ID: 28781284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.
    Sarode R; McFarland JG; Flomenberg N; Casper JT; Cohen EP; Drobyski WR; Ash RC; Horowitz MM; Camitta B; Lawton C
    Bone Marrow Transplant; 1995 Aug; 16(2):271-5. PubMed ID: 7581147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thrombotic microangiopathy in adults].
    Barrientos GJ; Michelangelo H
    Medicina (B Aires); 2006; 66(4):289-95. PubMed ID: 16977962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in children and adolescents.
    Lowe EJ; Werner EJ
    Semin Thromb Hemost; 2005 Dec; 31(6):717-30. PubMed ID: 16388423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary and Secondary Thrombotic Microangiopathy Referred to a Single Plasma Exchange Center for Suspected Thrombotic Thrombocytopenic Purpura: 2000-2011.
    Dahlan R; Sontrop JM; Li L; Ghadieh O; Clark WF
    Am J Nephrol; 2015; 41(6):429-37. PubMed ID: 26183258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative.
    Bendapudi PK; Li A; Hamdan A; Uhl L; Kaufman R; Stowell C; Dzik W; Makar RS
    Br J Haematol; 2015 Dec; 171(5):836-44. PubMed ID: 26314936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Masset C; Dubois B; Rorive G
    Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombotic microangiopathies: an update.
    Franchini M
    Hematology; 2006 Jun; 11(3):139-46. PubMed ID: 17325953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
    Mehmood T; Taylor M; Winters JL
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza-associated thrombotic microangiopathies.
    Bitzan M; Zieg J
    Pediatr Nephrol; 2018 Nov; 33(11):2009-2025. PubMed ID: 28884355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study.
    Henry N; Mellaza C; Fage N; Beloncle F; Genevieve F; Legendre G; Orvain C; Garnier AS; Cousin M; Besson V; Subra JF; Duveau A; Augusto JF; Brilland B
    Front Med (Lausanne); 2021; 8():566678. PubMed ID: 33718396
    [No Abstract]   [Full Text] [Related]  

  • 39. Predictors of response and relapse in a cohort of adults with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a single-institution experience.
    Tuncer HH; Oster RA; Huang ST; Marques MB
    Transfusion; 2007 Jan; 47(1):107-14. PubMed ID: 17207238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L
    Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.